title: Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
abstract: OBJECTIVE
  An association of Apolipoprotein B (Apo B) with coronary artery disease (CAD) independent of LDL cholesterol (LDLc) concentrations has been reported in white population. This analysis was taken up to study whether the higher CAD risk in Asian Indians with diabetes could be explained by possible alterations in Apo B and Apolipoprotein A1 (Apo A1) concentrations.
  
  
  METHODS
  The study group consisted of four hundred and forty seven men aged > or = 25 years, 167 with CAD and 280 with no CAD, classified by coronary angiography. Plasma lipid profile including total cholesterol, LDLc, Apo A1 and Apo B were done. Glucose tolerance was evaluated in all.
  
  
  RESULTS
  Age, BMI, Apo B, and Apo A1 were significantly associated with CAD in a multiple regression analysis. Hyper Apo B was more common than hyper LDLc in CAD (73.6% vs 20.4%, chi2 = 157, P < 0.001). Apo B concentrations were increased in diabetic subjects even in the presence of normal levels of LDLc and in the absence of CAD.
  
  
  CONCLUSIONS
  The study has shown that the apolipoproteins B and A1 provide better information regarding the risk of CAD. Apo B abnormalities exist in large percentages of CAD subjects despite having normal levels of LDLc. Diabetes per se enhances the Apo B concentrations and this could probably be one of the mechanisms of accelerated CAD in diabetes. Hyper Apo B may be an index of CAD risk.
authors.affiliation: Diabetes Research Centre and MV Hospital for Diabetes, Royapuram, Madras, India.
authors.forename: C
authors.initials: C
authors.lastname: Snehalatha
authors.forename: A
authors.initials: A
authors.lastname: Ramachandran
authors.forename: S
authors.initials: S
authors.lastname: Sivasankari
authors.forename: K
authors.initials: K
authors.lastname: Satyavani
authors.forename: V
authors.initials: V
authors.lastname: Viswanathan
authors.forename: Jaya
authors.initials: J
authors.lastname: Misra
authors.forename: M R
authors.initials: MR
authors.lastname: Girinath
authors.forename: I
authors.initials: I
authors.lastname: Sathyamurthy
mesh_terms: D000328:Adult; D016632:Apolipoprotein A-I / Q000378:metabolism*; D001055:Apolipoproteins B / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000378:metabolism; D003327:Coronary Disease / Q000453:epidemiology / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000378:metabolism*; D006801:Humans; D008297:Male; D015995:Prevalence; D012044:Regression Analysis; D012307:Risk Factors
chemical_list: D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D008078:Cholesterol, LDL